Early detection and yearly screenings are important in the fight against breast cancer. But what happens if you are one of the thousands of women each day who receives a devastating diagnosis of aggressive stage 4 breast cancer?

One key to is a therapy monitoring test called the Siemens HER-2/neu blood test - the only FDA cleared serum HER-2/neu blood test which can indicate whether metastatic breast cancer is progressing or responding to treatment. The test may allow doctors to monitor and treat their patients with more targeted, more effective therapies.

NOTE: The streaming audio and video files below require Microsoft© Windows Media© Player.

  Siemens HER-2/neu Blood Test [3.33 MB]

Siemens on TV archive